Screening without evidence of efficacy

British Medical Journal

Volumn 328, Issue 7435, 2004, Pages 301-302

  Law, Malcolm ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BREAST CANCER; BREAST EXAMINATION; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SCREENING; CLINICAL TRIAL; EDITORIAL; HISTOLOGY; HUMAN; LUNG CANCER; MAMMOGRAPHY; META ANALYSIS; MORBIDITY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TESTIS CANCER;

EID: 1042279461     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.328.7435.301     Document Type: Editorial

References (15)

1. Parkes C, Wald NJ, Murphy P, George L, Kirby R, Knekt P, et al. Prospective observational study to assess value of prostate specific antigen as screening test for prostate cancer. BMJ 1995;311:340-3.
2. Gann P H, Hennekens CH, Stampfer MJ. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA 1995;273:289-94.
3. Kranse R, Beemsterboer P, Rietbergen J, Habbema D, Hugosson J, Schröder FH. Predictors for biopsy outcome in the European randomised study of screening for prostate cancer (Rotterdam region). Prostate 1999;39:316-22.
4. Punglia RS, D'Amico AV, Catalona WJ, Roehl KA, Kuntz KM. Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen. N Engl J Med 2003;349:335-42.
5. Russo A, Autelitano M, Bellini A, Bisanti L. Estimate of population coverage with the prostate specific antigen (PSA) test to screen for prostate cancer in a metropolitan area of northern Italy. J Med Screen 2002;9:179-80.
6. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJJ, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991;324:1156-61.
7. Barry MJ. Prostate-specific-antigen testing for early diagnosis of prostate cancer. N Engl J Med 2001;344:1373-7.
8. Wolpaw DR. Early detection in lung cancer. Cancer Screening and Diagnosis 1996;80:63-82.
9. Lu-Yao G, Albertsen PC, Stanford JL, Stukel TA, Walker-Corkery ES, Barry MJ. Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut. BMJ 2002;325:740-3.
10. Woolf SH. Screening for prostate cancer with prostate-specific antigen. N Engl J Med 1995;23:1401-5.
11. Potosky AL, Legler J, Albertsen PC, Stanford JL, Gilliland FD, Hamilton AS, et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the prostate cancer outcomes study. J Natl Cancer Inst 2000;92:1582-92.
12. Thomas DB, Gao DL, Ray RM, Wang WW, Allison CJ, Liang F, et al. Randomised trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst 2002;94:1445-57.
13. Hackshaw AK, Paul EA. Breast self-examination and death from breast cancer: a meta-analysis. Br J Cancer 2003;88:1047-53.
14. Morris JK. Should testicular self examination be recommended? J Med Screen 1996;3:2.
15. Buetow SA. Testicular cancer: to screen or not to screen? J Med Screen 1996;3:3-6.